Login / Signup

Impacts of COVID-19 Pandemic on Sleep Quality Evaluated by Wrist Actigraphy: A Systematic Review.

Luiz Felipe Ferreira de SouzaMarize Julianelli-PeçanhaAna Carolina Coelho-OliveiraChristianne Martins Corrêa Silva BahiaLaisa Liane Paineiras-DomingosAline Reis-SilvaMárcia Cristina Moura-FernandesLuiza Carla Trindade-GusmãoRedha TaïarDanúbia da Cunha de Sá-CaputoAmandine RapinMário Bernardo-Filho
Published in: Journal of clinical medicine (2023)
COVID-19 has probably contributed as a risk factor for sleep disturbance. Actigraphy has been used to evaluate sleep complaints in self-isolated populations and frontline doctors during the COVID-19 pandemic. This systematic review aims to summarize the impact of the COVID-19 pandemic on sleep through wrist actigraphy, estimating sleep latency, total sleep time, awakening-after-sleep onset, and sleep efficiency. Searches were conducted of observational studies on the PubMed, Embase, Scopus, Web of Science, and PEDro databases from 1 December 2019 to 31 December 2022. Ninety articles were found, and given the eligibility criteria, fifteen were selected. Six studies were classified by the National Health and Medical Research Council as evidence level IV, two studies as level III-3, and seven studies as level III-2. According to the ACROBAT-NRSI instrument, three studies were classified as having a "serious" risk of bias, two as having "critical" risk, four as having "moderate" risk, and six as having "low" risk. In the selected publications, various populations were evaluated via actigraphy during the COVID-19 pandemic, with reports of "poor" sleep quality. Actigraphy may be a relevant tool to assess individual day-night rhythms and provide recommendations under enduring pandemic conditions. Moreover, as actigraphy presents objective data for sleep evaluations, it is suggested that this method be used in similar pandemics and that actigraphy be included as part of the sleep hygiene strategy.
Keyphrases
  • sleep quality
  • depressive symptoms
  • physical activity
  • systematic review
  • coronavirus disease
  • sars cov
  • healthcare
  • randomized controlled trial
  • public health
  • case control
  • big data
  • electronic health record